These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 10395472)

  • 1. Nonapeptide analogues containing (R)-3-hydroxybutanoate and beta-homoalanine oligomers: synthesis and binding affinity to a class I major histocompatibility complex protein.
    Poenaru S; Lamas JR; Folkers G; López de Castro JA; Seebach D; Rognan D
    J Med Chem; 1999 Jul; 42(13):2318-31. PubMed ID: 10395472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-based design of nonnatural ligands for the HLA-B27 protein.
    Dédier S; Krebs S; Lamas JR; Poenaru S; Folkers G; López de Castro JA; Seebach D; Rognan D
    J Recept Signal Transduct Res; 1999; 19(1-4):645-57. PubMed ID: 10071790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of two chemically modified peptide epitopes for the class I MHC protein HLA-B*2705.
    Jones MA; Hislop AD; Snaith JS
    Org Biomol Chem; 2006 Oct; 4(20):3769-77. PubMed ID: 17024283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic anticancer vaccine candidates: rational design of antigenic peptide mimetics that activate tumor-specific T-cells.
    Douat-Casassus C; Marchand-Geneste N; Diez E; Gervois N; Jotereau F; Quideau S
    J Med Chem; 2007 Apr; 50(7):1598-609. PubMed ID: 17328535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-canonical anchor motif peptides bound to MHC class I induce cellular responses.
    Lazoura E; Lodding J; Farrugia W; Day S; Ramsland PA; Apostolopoulos V
    Mol Immunol; 2009 Mar; 46(6):1171-8. PubMed ID: 19118903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmentation of the affinity of HLA class I-binding peptides lacking primary anchor residues by manipulation of the secondary anchor residues.
    Rovero P; Viganò S; Pegoraro S; Revoltella R; Riganelli D; Fruci D; Greco G; Butler RH; Tanigaki N
    J Pept Sci; 1995; 1(4):266-73. PubMed ID: 9223004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus type 1 Nef epitopes recognized in HLA-A2 transgenic mice in response to DNA and peptide immunization.
    Sandberg JK; Leandersson AC; Devito C; Kohleisen B; Erfle V; Achour A; Levi M; Schwartz S; Kärre K; Wahren B; Hinkula J
    Virology; 2000 Jul; 273(1):112-9. PubMed ID: 10891413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partially modified retro-inverso pseudopeptides as non-natural ligands for the human class I histocompatibility molecule HLA-A2.
    Guichard G; Connan F; Graff R; Ostankovitch M; Muller S; Guillet JG; Choppin J; Briand JP
    J Med Chem; 1996 May; 39(10):2030-9. PubMed ID: 8642561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of longer peptides to the H-2Kb heterodimer is restricted to peptides extended at their C terminus: refinement of the inherent MHC class I peptide binding criteria.
    Hörig H; Young AC; Papadopoulos NJ; DiLorenzo TP; Nathenson SG
    J Immunol; 1999 Oct; 163(8):4434-41. PubMed ID: 10510385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fab antibodies capable of blocking T cells by competitive binding have the identical specificity but a higher affinity to the MHC-peptide-complex than the T cell receptor.
    Neumann F; Sturm C; Hülsmeyer M; Dauth N; Guillaume P; Luescher IF; Pfreundschuh M; Held G
    Immunol Lett; 2009 Aug; 125(2):86-92. PubMed ID: 19524620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substituting nonpeptidic spacers for the T cell receptor-binding part of class I major histocompatibility complex-binding peptides.
    Krebs S; Lamas JR; Poenaru S; Folkers G; de Castro JA; Seebach D; Rognan D
    J Biol Chem; 1998 Jul; 273(30):19072-9. PubMed ID: 9668090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular dynamics and structure-based drug design for predicting non-natural nonapeptide binding to a class I MHC protein.
    Scapozza L; Rognan D; Folkers G; Daser A
    Acta Crystallogr D Biol Crystallogr; 1995 Jul; 51(Pt 4):541-9. PubMed ID: 15299842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble class I MHC with beta2-microglobulin covalently linked peptides: specific binding to a T cell hybridoma.
    White J; Crawford F; Fremont D; Marrack P; Kappler J
    J Immunol; 1999 Mar; 162(5):2671-6. PubMed ID: 10072510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformational changes of gp120 in epitopes near the CCR5 binding site are induced by CD4 and a CD4 miniprotein mimetic.
    Zhang W; Canziani G; Plugariu C; Wyatt R; Sodroski J; Sweet R; Kwong P; Hendrickson W; Chaiken I
    Biochemistry; 1999 Jul; 38(29):9405-16. PubMed ID: 10413516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-dimensional structure of H-2Dd complexed with an immunodominant peptide from human immunodeficiency virus envelope glycoprotein 120.
    Li H; Natarajan K; Malchiodi EL; Margulies DH; Mariuzza RA
    J Mol Biol; 1998; 283(1):179-91. PubMed ID: 9761682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possibilities and limitations in the rational design of modified peptides for T cell mediated immunotherapy.
    de Haan EC; Moret EE; Wagenaar-Hilbers JP; Liskamp RM; Wauben MH
    Mol Immunol; 2005 Feb; 42(3):365-73. PubMed ID: 15589325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ranking potential binding peptides to MHC molecules by a computational threading approach.
    Altuvia Y; Schueler O; Margalit H
    J Mol Biol; 1995 Jun; 249(2):244-50. PubMed ID: 7540211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the polymorphic residues in HLA-DR molecules in allele-specific binding of peptide ligands.
    Marshall KW; Liu AF; Canales J; Perahia B; Jorgensen B; Gantzos RD; Aguilar B; Devaux B; Rothbard JB
    J Immunol; 1994 May; 152(10):4946-57. PubMed ID: 8176213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A structure-based approach for prediction of MHC-binding peptides.
    Altuvia Y; Margalit H
    Methods; 2004 Dec; 34(4):454-9. PubMed ID: 15542371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide binding inhibits aggregation of soluble MHC class II in solution.
    Arimilli S; Astafieva I; Mukku PV; Cardoso C; Deshpande S; Nag B
    IUBMB Life; 1999 Nov; 48(5):483-91. PubMed ID: 10637763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.